Finding and helping people with early psychosis sooner
Early Stage Identification and Engagement to Reduce the Duration of Untreated Psychosis: Evaluating the Impact of Screening and Systematic Communication
This project aims to find young people experiencing early signs of psychosis more quickly and connect them with specialized care to improve their well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11127647 on NIH RePORTER |
What this research studies
We know that getting help for psychosis early can make a big difference in recovery, but often there's a long delay. This project is adapting a successful screening method from the Netherlands to use in New York, helping to identify individuals who are showing early signs of psychosis when they seek mental health services. We will also introduce a new way to share information about psychosis and treatment options with patients and their families. Our goal is to reduce the time between when psychosis symptoms start and when someone begins receiving specialized care.
Who could benefit from this research
Good fit: Ideal candidates for this research would be young people seeking mental health services who may be experiencing early symptoms of psychosis.
Not a fit: Patients who have already received treatment for established psychosis or those not seeking mental health services at participating clinics may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to faster access to specialized care for individuals with early psychosis, potentially improving their long-term recovery and quality of life.
How similar studies have performed: A similar detection approach has shown success in the Netherlands, and a pilot version has been successfully established at Mount Sinai Health System.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Landa, Yulia — Icahn School of Medicine at Mount Sinai
- Study coordinator: Landa, Yulia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.